圣诺生物：股东计划减持合计不超0.0240%股份

Core Viewpoint - The company announced that two executives plan to reduce their shareholdings due to personal financial needs, which may impact investor sentiment and stock performance [1] Summary by Relevant Sections Executive Shareholding Reduction - The company's Vice President, Ma Zhonggang, and the Director, Vice President, and Chief Financial Officer, Wu Li, intend to reduce their holdings through centralized bidding or block trading [1] - Ma Zhonggang plans to reduce up to 18,816 shares, representing no more than 0.0120% of the company's total share capital [1] - Wu Li also plans to reduce up to 18,816 shares, similarly representing no more than 0.0120% of the company's total share capital [1] Timeline and Compliance - The reduction period is set to begin 15 trading days after the announcement, lasting from December 23, 2025, to March 22, 2026 [1] - The shares to be reduced are sourced from equity incentives, and the implementation of the reduction plan will strictly adhere to relevant laws and regulations [1]